These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 6644314)

  • 1. Central catecholamine metabolism in vivo and the cognitive and motor deficits in Parkinson's disease.
    Mann JJ; Stanley M; Kaplan RD; Sweeney J; Neophytides A
    J Neurol Neurosurg Psychiatry; 1983 Oct; 46(10):905-10. PubMed ID: 6644314
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Central amine metabolism in Alzheimer's disease: in vivo relationship to cognitive deficit.
    Mann JJ; Stanley M; Neophytides A; de Leon MJ; Ferris SH; Gershon S
    Neurobiol Aging; 1981; 2(1):57-60. PubMed ID: 7266742
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platelet MAO activity and monoamine metabolites in cerebrospinal fluid in depressed and suicidal patients and in healthy controls.
    Oreland L; Wiberg A; Asberg M; Träskman L; Sjöstrand L; Thorén P; Bertilsson L; Tybring G
    Psychiatry Res; 1981 Feb; 4(1):21-9. PubMed ID: 6164071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CSF monoamine metabolite levels in Alzheimer's and Parkinson's disease.
    Gibson CJ; Logue M; Growdon JH
    Arch Neurol; 1985 May; 42(5):489-92. PubMed ID: 2581531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monoamine metabolite concentrations in lumbar cerebrospinal fluid of patients with histologically verified Alzheimer's dementia.
    Palmer AM; Sims NR; Bowen DM; Neary D; Palo J; Wikstrom J; Davison AN
    J Neurol Neurosurg Psychiatry; 1984 May; 47(5):481-4. PubMed ID: 6204017
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CSF monoamine metabolites in mania.
    Swann AC; Secunda S; Davis JM; Robins E; Hanin I; Koslow SH; Maas JW
    Am J Psychiatry; 1983 Apr; 140(4):396-400. PubMed ID: 6188381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 3-methoxy-4-hydroxyphenylglycol, 5-hydroxyindoleacetic acid, and homovanillic acid in human cerebrospinal fluid. Storage and measurement by reversed-phase high-performance liquid chromatography and coulometric detection using 3-methoxy-4-hydroxyphenyllactic acid as an internal standard.
    Javors MA; Bowden CL; Maas JW
    J Chromatogr; 1984 Dec; 336(2):259-69. PubMed ID: 6085084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cerebrospinal fluid monoamine metabolites during alcohol withdrawal syndrome and recovered state.
    Fujimoto A; Nagao T; Ebara T; Sato M; Otsuki S
    Biol Psychiatry; 1983 Oct; 18(10):1141-52. PubMed ID: 6197099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of amiflamine on cerebrospinal fluid amine metabolites in the rhesus monkey.
    Garrick NA; Seppala T; Linnoila M; Murphy DL
    Eur J Pharmacol; 1985 Mar; 110(1):1-9. PubMed ID: 2408906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cerebrospinal fluid concentration of biogenic amine metabolites in idiopathic apnea of prematurity.
    Bhat AM; Scanlon JW; Lavenstein B; Chuang L; Karoum F
    Biol Neonate; 1983; 43(1-2):16-22. PubMed ID: 6850011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monoamine metabolites in human cerebrospinal fluid: indicators of neuronal activity?
    Scheinin M
    Med Biol; 1985; 63(1):1-17. PubMed ID: 2582215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spinal reflexes and the concentrations of 5-HIAA, MHPG, and HVA in lumbar cereborspinal fluid after spinal lesions in man.
    Ashby P; Verrier M; Warsh JJ; Price KS
    J Neurol Neurosurg Psychiatry; 1976 Dec; 39(12):1191-200. PubMed ID: 1011029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Postmortem changes in the levels of monoamine metabolites in human cerebrospinal fluid.
    Endo T; Hara S; Kuriiwa F; Kano S
    Forensic Sci Int; 1990 Jan; 44(1):61-8. PubMed ID: 1689267
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aggression in humans correlates with cerebrospinal fluid amine metabolites.
    Brown GL; Goodwin FK; Ballenger JC; Goyer PF; Major LF
    Psychiatry Res; 1979 Oct; 1(2):131-9. PubMed ID: 95232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stability of monoamine metabolites in human cerebrospinal fluid.
    Langlais PJ; Bird ED; McEntee WJ
    Ann Neurol; 1982 Jul; 12(1):48-51. PubMed ID: 6180677
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amine metabolites in ventricular cerebrospinal fluid in coma.
    Yates CM; Tsementzis SA; Wilson H
    J Neurol Neurosurg Psychiatry; 1979 Oct; 42(10):887-91. PubMed ID: 512664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simultaneous determination of 3-methoxy-4-hydroxyphenylglycol, 5-hydroxyindoleacetic acid, and homovanillic acid in cerebrospinal fluid with high-performance liquid chromatography using electrochemical detection.
    Scheinin M; Chang WH; Kirk KL; Linnoila M
    Anal Biochem; 1983 May; 131(1):246-53. PubMed ID: 6193730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monoamine metabolites in human cerebrospinal fluid. HPLC/ED method.
    Mena MA; Aguado EG; de Yebenes JG
    Acta Neurol Scand; 1984 Apr; 69(4):218-25. PubMed ID: 6204498
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monoamine metabolites in cerebrospinal fluid in multiple sclerosis.
    Davidson D; Pullar IA; Mawdsley C; Kinloch N; Yates CM
    J Neurol Neurosurg Psychiatry; 1977 Aug; 40(8):741-5. PubMed ID: 925693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential effects of clorgyline on catecholamine and indoleamine metabolites in the cerebrospinal fluid of rhesus monkeys.
    Garrick NA; Scheinin M; Chang WH; Linnoila M; Murphy DL
    Biochem Pharmacol; 1984 May; 33(9):1423-7. PubMed ID: 6203542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.